Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BSA
|
|||
| Drug Name |
US9127005, P2B
|
|||
| Synonyms |
SCHEMBL12965084; CHEMBL3910701; BDBM179743; US9127005, P2B
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H27F2N3O2
|
|||
| Canonical SMILES |
CC(CN1CCC2(CC1)C(CNC2=O)C3=CC=C(C=C3)F)NC(=O)C4=CC=C(C=C4)F
|
|||
| InChI |
1S/C24H27F2N3O2/c1-16(28-22(30)18-4-8-20(26)9-5-18)15-29-12-10-24(11-13-29)21(14-27-23(24)31)17-2-6-19(25)7-3-17/h2-9,16,21H,10-15H2,1H3,(H,27,31)(H,28,30)/t16-,21?/m0/s1
|
|||
| InChIKey |
ZRRZCDIHCHFDRR-BJQOMGFOSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phospholipase D1 (PLD1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Phospholipase D1 (PLD1) | Target's Patent Info | [1] | |
| BioCyc | Phospholipases | |||
| KEGG Pathway | Glycerophospholipid metabolism | |||
| Ether lipid metabolism | ||||
| Metabolic pathways | ||||
| Ras signaling pathway | ||||
| cAMP signaling pathway | ||||
| Sphingolipid signaling pathway | ||||
| Endocytosis | ||||
| Fc gamma R-mediated phagocytosis | ||||
| Glutamatergic synapse | ||||
| GnRH signaling pathway | ||||
| Pathways in cancer | ||||
| Pancreatic cancer | ||||
| Choline metabolism in cancer | ||||
| Panther Pathway | Angiogenesis | |||
| Ras Pathway | ||||
| Pathway Interaction Database | RhoA signaling pathway | |||
| Arf6 trafficking events | ||||
| CDC42 signaling events | ||||
| Arf6 downstream pathway | ||||
| mTOR signaling pathway | ||||
| ErbB1 downstream signaling | ||||
| IL8- and CXCR1-mediated signaling events | ||||
| Alpha-synuclein signaling | ||||
| Reactome | Role of phospholipids in phagocytosis | |||
| WikiPathways | EGF/EGFR Signaling Pathway | |||
| TSH signaling pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Isoform selective phospholipase D inhibitors. US9127005. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.